G Medical Innovations Holdings

General Information

(IPOScoop has No Call on this initial public offering. Please see this statement in the prospectus: “Until recently, our Ordinary Shares traded on the Australian Securities Exchange operated by ASX Ltd. (or ASX), under the symbol “GMV.” On October 22, 2020, our Ordinary Shares were voluntarily delisted from the ASX. We have been approved to list the Ordinary Shares on the Nasdaq Global Market under the symbol “GMVD”, subject to notice of issuance. No assurance can be given that an active trading market for our Ordinary Shares will develop.”)

We are an early commercial stage healthcare company engaged in the development of next generation mobile health (or mHealth) and telemedicine solutions and monitoring service platforms. We believe we are at the forefront of the digital health revolution in developing the next generation mobile technologies and services that are designed to empower consumers, patients and providers to better monitor, manage and improve clinical and personal health outcomes, especially for those who suffer from cardiovascular disease (or CVD), pulmonary disease and diabetes.


Industry: Surgical & Medical Instruments & Apparatus
Employees: 73
Founded: 2014
Contact Information
Address 5 Oppenheimer St. 1500 S Lake Side Rehovot 7670105, Israel
Phone Number +972.544.33.8822
Web Address https://gmedinnovations.com/
View Prospectus: G Medical Innovations Holdings
Financial Information
Market Cap $358.62mil
Revenues $4.6 mil (last 12 months)
Net Income $-13.3 mil (last 12 months)
IPO Profile
Symbol GMVD
Exchange NASDAQ
Shares (millions): 5.0
Price range $5.00 - $7.00
Est. $ Volume $30.0 mil
Manager / Joint Managers Boustead Securities/ Fosun Hani
CO-Managers -
Expected To Trade: 11/24/2020
Status: Withdrawn
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change